Alzheimer’s remains one of the most feared diseases in the United States. Affecting approximately 6.2 million Americans, the incidence is expected to triple by 2050. After decades of research, no truly effective medical treatment exists.
The currently approved Alzheimer’s medications are, unfortunately, ineffective in stopping or slowing this devastating disease, which robs victims of their lives long before they’re gone.
It may be that scientists are looking in the wrong places for an effective treatment. Rather than a magic pill, it may be something as basic as a combination of anti-inflammatories, proper diet and supplements, and avoidance of toxins.
The first new treatment for Alzheimer’s in 18 years, Aduhelm, was designed to remove amyloid plaques in the brain. These plaques are seen on autopsy and have long been thought to be associated with Alzheimer’s. Even though Aduhelm targeted the plaques, it was ineffective in stopping or reversing cognitive decline. The Food and Drug Administration gave conditional approval for Aduhelm in June 2021 over the objections of an advisory panel. It also wasn’t recommended by European authorities. Most experts agree that Aduhelm has been disappointing at best….
-
Recent Posts
-
Archives
- May 2025
- April 2025
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- September 2013
- July 2013
- March 2013
- January 2013
- December 2012
- November 2012
- December 1
-
Meta